Web Results

Silverman v. United States


Silverman v. United States, 365 U.S. 505 (1961), was a United States Supreme Court case in which the Court unanimously held that a federal officer may not, ...

A prospective study comparing infection risk and disease activity in ...


Sep 18, 2014 ... The total infection rate ratio for TNF versus non-TNF group subjects ... retrospective cohort studies by Beukelman et al. demonstrated that JIA ..... Lovell DJ, Giannini EH, Reiff A, Cawkwell GD, Silverman ED, Nocton JJ, et al. ... Listing J, Strangfeld A, Kary S, Rau R, von Hinueber U, Stoyanova-Scholz M, et al.

Silverman et al., 2009 - Google Scholar

scholar.google.com/scholar_lookup?title=Coral reefs may start dissolving when atmospheric CO2 doubles&author=Silverman&publication_year=2009

Staphylococcus aureus Virulence Factors Synthesis is Controlled by ...


Dec 1, 2010 ... v. Table of Contents .... and MgrA, are regulators of virulence (Ingavale, van Wamel et al. .... or depleting innate-like B cells (Goodyear and Silverman 2004; ... and caspase-independent apoptosis (Haslinger, Strangfeld et al.

Staphylococcus aureusα-toxin induces apoptosis in peripheral ...


Aug 15, 2003 ... Katrin Strangfeld, ... which cleave various cellular substrates, thereby inducing the demise of the cell (Los et al., 1999). .... although the protective effect was less pronounced at high concentrations (1% v/v) of the bacterial supernatants. ..... lymphocytes (Weber et al., 2000; Goodyear and Silverman, 2003).

Staphylococcus aureus Protein A Binds to Osteoblasts and Triggers ...


Apr 15, 2011 ... (B+C) To measure Annexin V binding pelleted osteoblasts were ..... O'Seaghdha M, van Schooten CJ, Kerrigan SW, Emsley J, Silverman GJ, et al. .... Haslinger- Loffler B, Kahl BC, Grundmeier M, Strangfeld K, Wagner B, et al.

Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α ...


Original Article from The New England Journal of Medicine — Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent.

Positivity for anti-cyclic citrullinated peptide is associated with a ...


May 21, 2012 ... RF-positivity (75.6% vs 66.7%, p=0.03 in univariate analysis) and anti-CCP positivity (75.9% vs 62.2, p=0.001) were more frequent .... Strangfeld A,; Hierse F, ; Rau R,; et al .... Silverman GJ,; Schwartzman S,; Townsend M,; et al.

EULAR recommendations for vaccination in paediatric patients with ...


Aug 3, 2011 ... Heijstek MW, Ott de Bruin LM, Bijl M, et al. Ann Rheum Dis .... vaccination versus rheumatic diseases after the first search ( figure 1 ). ...... Silverman E, Mouy R, Spiegel L, et al. .... Strangfeld A, Listing J, Herzer P, et al. Risk of ...

Download - eScholarship@UMMS - University of Massachusetts ...


Jul 1, 2015 ... Silverman featuring research articles on clinical subjects from scientists working is a monthly ... moderate/high disease activity at baseline exposed to ≥ 2 versus 1 prior anti-TNF was 0.40 (95% CI ... Harrold, et al: Real-world effectiveness of RTX ...... Zink A, Strangfeld A, Schneider M, Herzer P, Hierse F,.

More Info

Anti-TNF therapy is associated with an increased risk of serious ...


Jul 31, 2010 ... The unadjusted rates of SI were higher in the anti-TNF cohort (42 vs 32 events per 1000 patient-years of follow-up). Univariate ..... Zink A,; Strangfeld A,; Schneider M,; et al .... Abraham E,; Wunderink R,; Silverman H,; et al.

Leflunomide in the treatment of rheumatoid arthritis - UpToDate


Apr 21, 2015 ... Silverman E, Mouy R, Spiegel L, et al. Leflunomide ... Dziedziejko V, Kurzawski M , Safranow K, et al. .... Strangfeld A, Hierse F, Kekow J, et al.

Positivity for anti-cyclic citrullinated peptide is associated with a ...


May 21, 2012 ... Gottenberg JE, Ravaud P, Cantagrel A, et al. Ann Rheum Dis ... (anti-CCP)- positivity (75.9% vs 62.2%, p= 0.001) were ..... Strangfeld A, Hierse F, Rau R, et al . Risk of ... Silverman GJ, Schwartzman S, Townsend M, et al.